Skip to main content

and
  1. Article

    A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus

    Microalbuminuria is considered the first clinical sign of kidney dysfunction and is associated with a poor renal and cardiovascular prognosis in type 2 diabetes. Detection of patients who are prone to develop ...

    S. S. Roscioni, D. de Zeeuw, M. E. Hellemons, H. Mischak, P. Zürbig in Diabetologia (2013)

  2. Article

    Open Access

    High serum potassium levels after losartan can reflect more severe renal disease. Reply to Gonçalves AR, El Nahas AM [letter]

    S. S. Roscioni, Y. Miao, D. de Zeeuw, H. J. Lambers Heerspink in Diabetologia (2011)

  3. Article

    Open Access

    Erratum to: Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial

    Y. Miao, D. Dobre, H. J. Lambers Heerspink, B. M. Brenner, M. E. Cooper in Diabetologia (2011)

  4. Article

    Open Access

    Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial

    To assess the effect of an angiotensin receptor blocker (ARB) on serum potassium and the effect of a serum potassium change on renal outcomes in patients with type 2 diabetes and nephropathy.

    Y. Miao, D. Dobre, H. J. Lambers Heerspink, B. M. Brenner, M. E. Cooper in Diabetologia (2011)

  5. Article

    Adverse effects of left ventricular hypertrophy in the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study

    We explored the impact of baseline left ventricular hypertrophy (LVH) and losartan treatment on renal and cardiovascular (CV) events in 1,513 patients from the Reduction of Endpoints in NIDDM with the Angioten...

    G. Boner, M. E. Cooper, K. McCarroll, B. M. Brenner, D. de Zeeuw in Diabetologia (2005)

  6. Article

    40th EASD Annual Meeting of the European Association for the Study of Diabetes

    M. Veitenhansl, K. Stegner, F.-X. Hierl, C. Dieterle, H. Feldmeier, B. Gutt in Diabetologia (2004)

  7. Article

    35th Annual Meeting of the European Association for the Study of Diabetes

    A. Melander, J. Olsson, G. Lindberg, A. Salzman, T. Howard, P. Stang in Diabetologia (1999)

  8. No Access

    Article

    Pharmacological zero for electromagnetic renal blood flow measurement

    Measurement of blood flow in chronically instrumented laboratory animals using electromagnetic flow probes depends on a reference “zero flow” value. The latter is usually obtained by mechanical vessel occlusio...

    G. J. Jonker, D. de Zeeuw, R. M. Huisman, G. K. van der Hem in Pflügers Archiv (1985)